2 weeks Ago By Defense World Staff
Curis ( NASDAQ:CRIS – Get Free Report ) will be posting its quarterly earnings results before the market opens on Thursday, November 14th. Analysts expect Curis to post earnings of ($1.88) per share for the quarter.
Individual interested in listening to the company’s earnings conference call can do so using this link . Curis Stock Down 4.6 % CRIS opened at $4.
12 on Wednesday. The stock has a market cap of $24.63 million, a P/E ratio of -0.
52 and a beta of 3.35. Curis has a 12 month low of $4.
00 and a 12 month high of $17.49. The company has a fifty day simple moving average of $5.
11 and a 200 day simple moving average of $7.31. Analysts Set New Price Targets Separately, HC Wainwright dropped their price target on Curis from $26.
00 to $20.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. About Curis ( Get Free Report ) Curis, Inc, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. See Also Five stocks we like better than Curis How to Use the MarketBeat Dividend Calculator Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 Are Penny Stocks a Good Fit for Your Portfolio? Is Tesla’s Valuation a Bubble or Backed by Real Growth? How Technical Indicators Can Help You Find Oversold Stocks Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for Curis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curis and related companies with MarketBeat.com's FREE daily email newsletter .
.
